Prognostic Role of Preoperative Duke Pancreatic Monoclonal Antigen Type 2 Levels in Patients with Pancreatic Cancer.
Yuji ShimizuTeiichi SugiuraRyo AshidaKatsuhisa OhgiMihoko YamadaShimpei OtsukaKatsuhiko UesakaPublished in: Annals of surgical oncology (2023)
In PC, DUPAN-2 may be useful as a biomarker complementary with CA19-9. The combination of these two markers may aid in the preoperative prediction of prognosis for patients with PC.